Skip to main content

What the label lists and what reports show

Ganirelix side effects

Ganirelix's FDA label lists its adverse reactions in its own words. FAERS holds 639 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is ovarian hyperstimulation syndrome (253 reports).

  • Generic listed

Check it at the source: the ganirelix FDA label on DailyMed (effective November 13, 2025, Organon LLC); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

The safety of Ganirelix Acetate Injection was evaluated in two randomized, parallel-group, multicenter controlled clinical studies. Treatment duration for Ganirelix Acetate ranged from 1 to 14 days. Table IV represents adverse events (AEs) from first day of Ganirelix Acetate administration until confirmation of pregnancy by ultrasound at an incidence of ≥ 1% in Ganirelix Acetate-treated subjects without regard to causality. TABLE IV: Incidence of common adverse events (Incidence ≥ 1% in Ganirelix Acetate-treated subjects). Completed controlled clinical studies (All-subjects-treated group). …

TABLE IV: Incidence of common adverse events (Incidence ≥ 1% in Ganirelix Acetate-treated subjects). Completed controlled clinical studies (All-subjects-treated group).

Adverse Events Occurring in ≥ 1%Ganirelix Acetate N=794 % (n)
Abdominal Pain (gynecological)4.8 (38)
Death Fetal3.7 (29)
Headache3.0 (24)
Ovarian Hyperstimulation Syndrome2.4 (19)
Vaginal Bleeding1.8 (14)
Injection Site Reaction1.1 (9)
Nausea1.1 (9)
Abdominal Pain (gastrointestinal)1.0 (8)

Rows and numbers as the label prints them, under its own column headings (the first rows of a longer table where it runs on). A reaction in a trial table is not necessarily caused by the medicine, and trials differ from everyday use.

Source: FDA drug label, Organon LLC, effective November 13, 2025 (SPL set 32fb74ff-993a-49fe-8943-e029372b863e), via openFDA; the full label on DailyMed

What do FAERS reports show?

639 reports list ganirelix among the medicines taken, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 272 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 21 reactions below, 5 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Ovarian Hyperstimulation Syndrome (named in the label)253
  • Ascites58
  • Nausea (named in the label)37
  • Dyspnoea34
  • Abdominal Pain (named in the label)28
  • Drug Ineffective (a use or a product term, not a reaction)27
  • Headache (named in the label)26
  • Pleural Effusion22
  • Abdominal Distension20
  • Fatigue20
  • Maternal Exposure Before Pregnancy (a use or a product term, not a reaction)19
  • Injection Site Pain17
  • Needle Issue17
  • No Adverse Event (a use or a product term, not a reaction)17
  • Vomiting17
  • Maternal Exposure During Pregnancy (a use or a product term, not a reaction)15
  • Abortion14
  • Poor Quality Device Used14
  • Pain13
  • Abortion Spontaneous12
  • Pelvic Pain12
  • Product Storage Error12
  • Abdominal Discomfort11
  • Cardiovascular Disorder10
  • Injection Site Reaction (named in the label)10

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Ganirelix: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions